Noninvasive Determination of Fetal RhD Status Using Fetal DNA in Maternal Serum and PCR
- 1 March 1999
- journal article
- Published by Springer Nature in Journal of the Society for Gynecologic Investigation
- Vol. 6 (2) , 64-69
- https://doi.org/10.1177/107155769900600203
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Molecular analysis of the rhd genotype in fetuses at risk for rhd hemolytic diseasePublished by Wolters Kluwer Health ,2000
- Quantitative Analysis of Fetal DNA in Maternal Plasma and Serum: Implications for Noninvasive Prenatal DiagnosisAmerican Journal of Human Genetics, 1998
- Specificity and sensitivity of RHD genotyping methods by PCR‐based DNA amplificationBritish Journal of Haematology, 1997
- Molecular basis of the D variant phenotypes DNU and DII allows localization of critical amino acids required for expression of Rh D epitopes epD3, 4 and 9 to the sixth external domain of the Rh D proteinBritish Journal of Haematology, 1997
- Prenatal Diagnosis of the RhD Fetal Blood Type on Amniotic Fluid by Polymerase Chain ReactionObstetrics & Gynecology, 1996
- Fluorescent polymerase chain reaction: Part I. A new method allowing genetic diagnosis and DNA fingerprinting of single cellsHuman Reproduction Update, 1996
- Accuracy of prenatal determination of RhD type status by polymerase chain reaction with amniotic cellsAmerican Journal of Obstetrics and Gynecology, 1995
- Management of Platelet and RhD Maternal Immunizations by PCR Phenotypings after Early AmniocentesisFetal Diagnosis and Therapy, 1995
- Defining the Rh blood group antigens: Biochemistry and molecular geneticsBlood Reviews, 1994
- High‐sensitive fluorescent DNA sequencing and its application for detection and mass‐screening of point mutationsElectrophoresis, 1992